| 1.66 Data as of Jun 19 |  -0.05 / -2.92%Today’s Change | 1.50 Today|||52-Week Range 3.51 | -21.33% Year-to-Date |
| Previous close | 1.71 |
| Today’s open | 1.72 |
| Day’s range | 1.65 - 1.75 |
| Volume | 264,108 |
| Average volume (3 months) | 445,623 |
| Market cap | $91.1M |
| Dividend yield | -- |
| Earnings growth (last year) | -2.15% |
| Earnings growth (this year) | +1.40% |
| Earnings growth (next 5 years) | +20.00% |
| Revenue growth (last year) | -66.49% |
| P/E ratio | NM |
| Price/Sales | 426.28 |
| Price/Book | 4.23 |
| Today’s change | Today’s % change | |
|---|---|---|
| CPIXCumberland Pharmaceu... | -0.01 | -0.20% |
| ANTHAnthera Pharmaceutic... | -0.02 | -2.69% |
| PRANPrana Biotechnology ... | -0.03 | -1.29% |
| ATHXAthersys Inc | -0.05 | -2.92% |
| Next reporting date | August 7, 2013 |
| EPS forecast (this quarter) | -$0.28 |
| Annual revenue (last year) | $195.0K |
| Annual profit (last year) | -$37.3M |
| Net profit margin | -19,135.90% |
Sector Health Technology |
Industry Biotechnology |
President, CEO, CFO, Treasurer & Director John G. Cooper, CPA |
Chief Operating Officer & Senior Vice President Thomas F. Miller, PhD, MBA |
Corporate headquarters Warrington, Pennsylvania |
.
